Department of Radiology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.
J Am Coll Radiol. 2010 May;7(5):351-9. doi: 10.1016/j.jacr.2009.12.015.
Advances in medical imaging have been associated with increased utilization and increased radiation exposure, especially for patients with chronic and recurrent conditions. The authors estimated the cumulative radiation doses from medical imaging for specific cohorts with chronic and recurrent conditions.
All patients diagnosed with hydrocephalus (n = 1,711), pulmonary thromboembolic disease (n = 3,220), renal colic (n = 5,855), and cardiac disease (n = 11,072) from January 1, 2000, to December 31, 2005, were retrospectively identified. Each imaging examination that used ionizing radiation from 2000 to 2008 was incorporated into an estimate of total effective dose and organ-specific doses. Patients with high levels of radiation exposure after 3 years (total effective dose > 50 mSv; dose to the ocular lens > 150 mSv) were identified.
The mean estimated effective doses for the surviving diagnostic cohorts after 3 years were 12.3 mSv for patients with hydrocephalus, 21.7 mSv for those with pulmonary thromboembolic disease, 18.7 mSv for those with renal colic, and 14.0 mSv for those with cardiac disease. Among patients with hydrocephalus, 26.3% (339 of 1,291) had radiation doses > 150 mSv to the ocular lens within 3 years. In all cohorts, the proportion of patients with total effective doses > 50 mSv within 3 years was significantly higher for those diagnosed in 2004 and 2005 than for those diagnosed in 2000 and 2001.
Patients with hydrocephalus, pulmonary thromboembolic disease, renal colic, and cardiac disease received radiation exposures that may put them at increased risk for cancer. Moreover, the proportion who received estimated total effective doses > 50 mSv within 3 years was significantly higher for those diagnosed most recently. It is the responsibility of institutions and physicians to critically evaluate their infrastructures, diagnostic strategies, and imaging techniques for each individual patient, with an eye toward minimizing cumulative medical radiation exposure.
医学影像学的进步与医疗利用率的提高和辐射暴露的增加有关,尤其是对于患有慢性和复发性疾病的患者。作者评估了特定慢性和复发性疾病患者群体的医疗影像学累积辐射剂量。
回顾性地确定了 2000 年 1 月 1 日至 2005 年 12 月 31 日期间诊断为脑积水(n = 1711)、肺血栓栓塞性疾病(n = 3220)、肾绞痛(n = 5855)和心脏病(n = 11072)的所有患者。将 2000 年至 2008 年期间使用电离辐射的所有影像学检查纳入总有效剂量和器官特异性剂量的估算中。确定了 3 年后(总有效剂量 > 50 mSv;眼晶状体剂量 > 150 mSv)暴露于高剂量辐射的患者。
3 年后存活诊断队列的平均估计有效剂量为脑积水患者 12.3 mSv,肺血栓栓塞性疾病患者 21.7 mSv,肾绞痛患者 18.7 mSv,心脏病患者 14.0 mSv。在脑积水患者中,有 26.3%(1291 例中有 339 例)在 3 年内眼晶状体受到的辐射剂量 > 150 mSv。在所有队列中,2004 年和 2005 年诊断的患者在 3 年内总有效剂量 > 50 mSv 的比例显著高于 2000 年和 2001 年诊断的患者。
患有脑积水、肺血栓栓塞性疾病、肾绞痛和心脏病的患者受到的辐射可能会增加他们患癌症的风险。此外,最近诊断的患者中,有比例显著更高的患者在 3 年内接受的估计总有效剂量 > 50 mSv。医疗机构和医生有责任仔细评估每个患者的基础设施、诊断策略和影像学技术,着眼于尽量减少累积医疗辐射暴露。